| Multiple Sclerosis |
1 |
1 |
| Biomarker |
0 |
0.99 |
| Traction |
0 |
0.3 |
| Cognitive Impairment |
0 |
0.28 |
| Disease-Modifying Therapy |
0 |
0.2 |
| Impairment |
0 |
0.2 |
| Neuroimaging |
0 |
0.2 |
| Clinically Isolated Syndrome (CIS) |
0 |
0.17 |
| Mild Cognitive Impairment |
0 |
0.11 |
| Brain |
0 |
0.1 |
| California |
0 |
0.1 |
| Central Nervous System |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Demyelination |
0 |
0.1 |
| Fellowship |
0 |
0.1 |
| Geriatrics |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Massachusetts |
0 |
0.1 |
| Memory |
0 |
0.1 |
| New York |
0 |
0.1 |
| Steroids |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.06 |